Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction

Abstract

Secreted Frizzled-related proteins (sFRPs) have emerged as key regulators of a wide range of developmental and disease processes. Most of the known functions of mammalian sFRPs have been attributed to their ability to antagonize Wnt signalling. Recently however, Xenopus laevis and zebrafish sFRP, Sizzled, was shown to function as an antagonist of Chordin processing by Tolloid-like metalloproteinases. This has led to the proposal that sFRPs may function as evolutionarily conserved antagonists of chordinase activities of this class of proteinases. In contrast to this proposal, we show here that the mammalian sFRP, sFRP2, does not affect Chordin processing, but instead, can serve as a direct enhancer of procollagen C proteinase activity of Tolloid-like metalloproteinases. We also show that the level of fibrosis, in which procollagen processing by Tolloid-like proteinases has a rate-limiting role, is markedly reduced in Sfrp2-null mice subjected to myocardial infarction. Importantly, this reduced level of fibrosis is accompanied by significantly improved cardiac function. This study thus uncovers a function for sFRP2 and a potential therapeutic application for sFRP2 antagonism in controlling fibrosis in the infarcted heart.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: sFRP2 enhances cleavage of procollagen, but not Chordin, by BMP1 and mTLL1.
Figure 2: sFRP2 binds BMP1 with a KD in the physiological range, predominantly through its Fzl domain.
Figure 3: sFRP2 and Szl bind Tolloid-like proteinases through non-protease domain sequences and BMP1/procollagen binding is enhanced by sFRP2.
Figure 4: Reduced processing of type I procollagen and deposition of collagen into ECM by Sfrp2−/− fibroblasts.
Figure 5: Induction of Sfrp2 and Bmp1 during the fibrosis phase in the infarcted heart.
Figure 6: Reduced fibrosis in the infarcted Sfrp2-deficient heart.
Figure 7: Improved cardiac function of the infarcted Sfrp2-null heart.

Similar content being viewed by others

References

  1. Rattner, A. et al. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc. Natl Acad. Sci. USA 94, 2859–2863 (1997).

    Article  CAS  Google Scholar 

  2. Mayr, T. et al. Fritz: a secreted frizzled-related protein that inhibits Wnt activity. Mech. Dev. 63, 109–125 (1997).

    Article  CAS  Google Scholar 

  3. Finch, P. W. et al. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc. Natl Acad. Sci. USA 94, 6770–6775 (1997).

    Article  CAS  Google Scholar 

  4. Melkonyan, H. S. et al. SARPs: a family of secreted apoptosis-related proteins. Proc. Natl Acad. Sci. USA 94, 13636–13641 (1997).

    Article  CAS  Google Scholar 

  5. Salic, A. N., Kroll, K. L., Evans, L. M. & Kirschner, M. W. Sizzled: a secreted Xwnt8 antagonist expressed in the ventral marginal zone of Xenopus embryos. Development 124, 4739–4748 (1997).

    CAS  PubMed  Google Scholar 

  6. Bodine, P. V. et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 18, 1222–1237 (2004).

    Article  CAS  Google Scholar 

  7. Barandon, L. et al. Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning. Circ. Res. 96, 1299–1306 (2005).

    Article  CAS  Google Scholar 

  8. Satoh, W., Gotoh, T., Tsunematsu, Y., Aizawa, S. & Shimono, A. Sfrp1 and Sfrp2 regulate anteroposterior axis elongation and somite segmentation during mouse embryogenesis. Development 133, 989–999 (2006).

    Article  CAS  Google Scholar 

  9. Suzuki, H. et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nature Genet. 36, 417–422 (2004).

    Article  CAS  Google Scholar 

  10. Zou, H. et al. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int. J. Cancer 116, 584–91 (2005).

    CAS  Google Scholar 

  11. Lee, J. L., Lin, C. T., Chueh, L. L. & Chang, C. J. Autocrine/paracrine secreted Frizzled-related protein 2 induces cellular resistance to apoptosis: a possible mechanism of mammary tumorigenesis. J. Biol. Chem. 279, 14602–14609 (2004).

    Article  CAS  Google Scholar 

  12. Zi, X. et al. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res. 65, 9762–9770 (2005).

    Article  CAS  Google Scholar 

  13. Dufourcq, P. et al. FrzA, a secreted frizzled related protein, induced angiogenic response. Circulation 106, 3097–3103 (2002).

    Article  Google Scholar 

  14. Oshima, T. et al. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood 106, 3160–3165 (2005).

    Article  CAS  Google Scholar 

  15. Kim, A. S., Anderson, S. A., Rubenstein, J. L., Lowenstein, D. H. & Pleasure, S. J. Pax-6 regulates expression of SFRP-2 and Wnt-7b in the developing CNS. J. Neurosci. 21, RC132 (2001).

    Article  CAS  Google Scholar 

  16. Barandon, L. et al. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. Circulation 108, 2282–2289 (2003).

    Article  CAS  Google Scholar 

  17. Roth, W. et al. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 19, 4210–4220 (2000).

    Article  CAS  Google Scholar 

  18. Lee, C. S., Buttitta, L. A., May, N. R., Kispert, A. & Fan, C. M. SHH-N upregulates Sfrp2 to mediate its competitive interaction with WNT1 and WNT4 in the somitic mesoderm. Development 127, 109–118 (2000).

    CAS  PubMed  Google Scholar 

  19. Kim, B. M., Buchner, G., Miletich, I., Sharpe, P. T. & Shivdasani, R. A. The stomach mesenchymal transcription factor Barx1 specifies gastric epithelial identity through inhibition of transient Wnt signaling. Dev. Cell 8, 611–622 (2005).

    Article  CAS  Google Scholar 

  20. Polesskaya, A., Seale, P. & Rudnicki, M. A. Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 113, 841–852 (2003).

    Article  CAS  Google Scholar 

  21. Lei, Q. et al. Wnt signaling inhibitors regulate the transcriptional response to morphogenetic Shh–Gli signaling in the neural tube. Dev. Cell 11, 325–337 (2006).

    Article  CAS  Google Scholar 

  22. Mirotsou, M. et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl Acad. Sci. USA 104, 1643–1648 (2007).

    Article  CAS  Google Scholar 

  23. Lee, H. X., Ambrosio, A. L., Reversade, B. & De Robertis, E. M. Embryonic dorsal-ventral signaling: secreted frizzled-related proteins as inhibitors of tolloid proteinases. Cell 124, 147–159 (2006).

    Article  CAS  Google Scholar 

  24. Muraoka, O. et al. Sizzled controls dorsoventral polarity by repressing cleavage of the Chordin protein. Nature Cell Biol. 8, 329–338 (2006).

    Article  CAS  Google Scholar 

  25. De Robertis, E. M. & Kuroda, H. Dorsal-ventral patterning and neural induction in Xenopus embryos. Annu. Rev. Cell Dev. Biol. 20, 285–308 (2004).

    Article  CAS  Google Scholar 

  26. Schier, A. F. & Talbot, W. S. Molecular genetics of axis formation in zebrafish. Annu. Rev. Genet. 39, 561–613 (2005).

    Article  CAS  Google Scholar 

  27. Hopkins, D. R., Keles, S. & Greenspan, D. S. The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol. 26, 508–523 (2007).

    Article  CAS  Google Scholar 

  28. Ge, G. & Greenspan, D. S. BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein. J. Cell Biol. 175, 111–120 (2006).

    Article  CAS  Google Scholar 

  29. Kawano, Y. & Kypta, R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116, 2627–2634 (2003).

    Article  CAS  Google Scholar 

  30. Banyai, L. & Patthy, L. The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Protein Sci. 8, 1636–1642 (1999).

    Article  CAS  Google Scholar 

  31. Ge, G., Fernandez, C. A., Moses, M. A. & Greenspan, D. S. Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. Proc. Natl Acad. Sci. USA 104, 10010–10015 (2007).

    Article  CAS  Google Scholar 

  32. Cleutjens, J. P., Blankesteijn, W. M., Daemen, M. J. & Smits, J. F. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc. Res. 44, 232–241 (1999).

    Article  CAS  Google Scholar 

  33. Swynghedauw, B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79, 215–262 (1999).

    Article  CAS  Google Scholar 

  34. Woessner, J. F., Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 93, 440–447 (1961).

    Article  CAS  Google Scholar 

  35. Berg, R. A. Determination of 3- and 4-hydroxyproline. Methods Enzymol. 82, 372–98 (1982).

    Article  CAS  Google Scholar 

  36. Wodarz, A. & Nusse, R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14, 59–88 (1998).

    Article  CAS  Google Scholar 

  37. Kessler, E. & Adar, R. Type I procollagen C-proteinase from mouse fibroblasts. Purification and demonstration of a 55-kDa enhancer glycoprotein. Eur. J. Biochem. 186, 115–121 (1989).

    Article  CAS  Google Scholar 

  38. Takahara, K. et al. Type I procollagen COOH-terminal proteinase enhancer protein: identification, primary structure, and chromosomal localization of the cognate human gene (PCOLCE). J. Biol. Chem. 269, 26280–26285 (1994).

    CAS  PubMed  Google Scholar 

  39. Moali, C. et al. Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. J. Biol. Chem. 280, 24188–24194 (2005).

    Article  CAS  Google Scholar 

  40. Ge, G., Zhang, Y., Steiglitz, B. M. & Greenspan, D. S. Mammalian tolloid-like 1 binds procollagen C-proteinase enhancer protein 1 and differs from bone morphogenetic protein 1 in the functional roles of homologous protein domains. J. Biol. Chem. 281, 10786–19798 (2006).

    Article  CAS  Google Scholar 

  41. Garrigue-Antar, L., Francois, V. & Kadler, K. E. Deletion of epidermal growth factor-like domains converts mammalian tolloid into a chordinase and effective procollagen C-proteinase. J. Biol. Chem. 279, 49835–49841 (2004).

    Article  CAS  Google Scholar 

  42. Martyn, U. & Schulte-Merker, S. The ventralized ogon mutant phenotype is caused by a mutation in the zebrafish homologue of Sizzled, a secreted Frizzled-related protein. Dev. Biol. 260, 58–67 (2003).

    Article  CAS  Google Scholar 

  43. Yabe, T. et al. Ogon/Secreted Frizzled functions as a negative feedback regulator of Bmp signaling. Development 130, 2705–2716 (2003).

    Article  CAS  Google Scholar 

  44. Sun, Y. & Weber, K. T. Infarct scar: a dynamic tissue. Cardiovasc. Res. 46, 250–256 (2000).

    Article  CAS  Google Scholar 

  45. Jugdutt, B. I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108, 1395–1403 (2003).

    Article  Google Scholar 

  46. Jugdutt, B. I. Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Curr. Drug Targets Cardiovasc. Haematol. Disord. 3, 1–30 (2003).

    Article  CAS  Google Scholar 

  47. Scott, I. C. et al. Mammalian BMP-1/Tolloid-related metalloproteinases, including novel family member mammalian Tolloid-like 2, have differential enzymatic activities and distributions of expression relevant to patterning and skeletogenesis. Dev. Biol. 213, 283–300 (1999).

    Article  CAS  Google Scholar 

  48. Pappano, W. N., Steiglitz, B. M., Scott, I. C., Keene, D. R. & Greenspan, D. S. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases. Mol. Cell Biol. 23, 4428–4438 (2003).

    Article  CAS  Google Scholar 

  49. Fisher, L. W., Stubbs, J. T., 3rd & Young, M. F. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand. Suppl. 266, 61–65 (1995).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Kuangfu Hsiao, Patricia Cobo and Guy Hoffman for technical assistance, and Tony Brown (Cornell) for providing information regarding qPCR primers for Wnt genes. K.K. and M.L. would like to acknowledge Rosemary Kraemer's teaching of technical procedures for the mouse myocardial infarction model. Work in the laboratory of A.K. is supported by funding from the German Research Foundation (DFG) for the Cluster of Excellence REBIRTH (from Regenerative Biology of Reconstructive Therapy), and by the European Union FP6 contract 'Heart Repair' (LSHM-CT-2005-018630). C.T.B. is an Established Investigator of the American Heart Association and is supported by the Snart Cardiovascular Fund. This work was supported in part by grants from the NIH (C.T.B, D.S.G, T.N.S).

Author information

Authors and Affiliations

Authors

Contributions

K.K., M.L., and Y.Z. conducted experiments and contributed to interpretation of data and writing of the manuscript; D.C.W. performed and analysed echocardiographic studies with K.K and C.Y.; C.T.B. contributed to the interpretation of echocardiographic and cardiac physiology data; T.G. conducted all in situ hybridization experiments; A.K. provided unpublished Sfrp2 genomic DNA clones, contributed to the interpretation of in situ hybridization data and writing of the manuscript; G.G. conducted the BIAcore and pulldown assays shown in Fig. 2; C.Y. conducted some of the MI operations; T.-C.L. conducted qRT–PCR experiments; G.H. participated in constructing DNA expression vectors; D.S.G. designed and oversaw biochemical and cell biology experiments and contributed to the interpretation of data and writing of the manuscript; T.N.S. oversaw the project, designed experiments, interpreted data and wrote the manuscript.

Corresponding authors

Correspondence to Daniel S. Greenspan or Thomas N. Sato.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

Supplementary Information (PDF 886 kb)

Supplementary Information

Supplementary movie 1 (MOV 3823 kb)

Supplementary Information

Supplementary Movie 2 (MOV 4063 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kobayashi, K., Luo, M., Zhang, Y. et al. Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol 11, 46–55 (2009). https://doi.org/10.1038/ncb1811

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncb1811

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing